Presentations 2022

Conference on Retroviruses and Opportunistic Infections, Virtual & In-Person February 12-16 2022

Poster presentation:

  • Trends in cancer incidence in different modern ART-eras among people living with HIV presented by Amanda Mocroft on behalf of the RESPOND Study Group. PRESENTATION
     
  • HIV/HBV/HCV triple infection, end stage liver disease and all-cause mortality presented by Amanda Mocroft on behalf of EuroSIDA Study Group. PRESENTATION
     

 

12th International Workshop on HIV & Women, Virtual, 6-8 April 2022

Poster presentation:

  • Characteristics of Women Living with HIV in the RESPOND Cohort presented by Jolie Hutchinson on behalf of the RESPOND Study Group. PRESENTATION
     

 

HIV Glasgow 2022, 23-26 October 2022

Oral presentation:

  • Risk of tuberculosis after initiation of antiretroviral therapy among people living with HIV in Europe presented by Isik Somuncu Johansen on behalf of the RESPOND Study Group. POSTER and PRESENTATION
     
  • Use of Preventive Measures for Cardiovascular Disease in People living with HIV presented by Nadine Jaschinski on behalf of the RESPOND Study Group. POSTER and PRESENTATION
     
  • Prevalence, outcomes, and factors associated with testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among people living with HIV across Europe in the multinational EuroSIDA cohort presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER and PRESENTATION
     

Poster presentation:

  • Initial plasma HIV-1 RNA and CD4+ T-cell count are determinants of virological outcomes with initial integrase inhibitor-based regimens: A prospective multinational RESPOND cohort consortium presented by Hortensia Álvarez on behalf of the RESPOND Study Group. POSTER